1227935-01-4

Basic information

• Product Name: ethyl 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylate
• Synonyms: ethyl 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylate
• CAS NO: 1227935-01-4
• Molecular Weight: 323.336
• Mol File: 1227935-01-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylate(1227935-01-4)
• EPA Substance Registry System: ethyl 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylate(1227935-01-4)

Safety Data

• Hazardous Substances Data: 1227935-01-4(Hazardous Substances Data)

Upstream product

• 1569-69-3 Cyclohexanethiol 
• 1227934-69-1 ethyl 2-bromo-4-(trifluoromethyl)oxazole-5-carboxylate 

Downstream Products

• 1227935-02-5 2-(cyclohexylthio)-4-trifluoromethyloxazole-5-carboxylic acid 
• 1227934-64-6 Cyclopentyl 4-[5-(2-(cyclohexylthio)-4-(trifluoromethyl)oxazole-5-carboxamido)pyridin-2-yl]piperazine-1-carboxylate 

Relevant articles and documents

INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE

The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).